As was exhibited in Japanese patients with T2DM, the genotype TT at the -108 C/T polymorphic site in the promoter region of the PON1 gene, which is associated with decreased PON1 expression, contributed to the unfavorable, proatherogenic lipid profile. This evidence concerns the gene PON1 and type 2 diabetes mellitus.